12214-full
LSK
Sex: F
Data Quality: 3 stars
MS: 20 yrs
Type: Secondary Progressive
Sensation: Moderate
Overall: Moderate
Cognition: severe
Vision: none
Speech: moderate
Swallowing: moderate
Upper limb: moderate
Walking: moderate
LSK
Female, 49 years
MA, United States
Primary Condition
MS and 5 more ▼
Type
Secondary Progressive
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

LSK's Rituximab is for:

  • MS

LSK has not reported any side effects for Rituximab.

LSK's Rituximab History (Stopped)
500 mg Weekly May 01 - 10, 2008
500 mg Weekly Jan 25 - Feb 05, 2009
500 mg Weekly Jun 22 - Jul 02, 2009
500 mg Every 3 months Jul 06, 2009 - Jan 01, 2012
Stopped Course of treatment ended May 10, 2008
Stopped Course of treatment ended Feb 05, 2009
Stopped Course of treatment ended Jul 02, 2009
Stopped Did not seem to work and Doctor's advice Jan 01, 2012
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Nov 01, 2009 500 mg Every 3 months Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 MildMildMildMild AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat
Jun 18, 2009   Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat

About Rituximab (Prescription Drug)

Rituximab is a medication in a class of medications called monoclonal antibodies and given by infusion. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

Learn more about Rituximab in our Rituximab Community Report.

Back to LSK's Profile